Greenwich LifeSciences Inc. is a biopharmaceutical company focused on the development of immunotherapy for the prevention of breast cancer recurrence. Their innovative approach, utilizing targeted peptides, has shown promising results in early clinical trials. As they continue to advance their research, Greenwich LifeSciences Inc. aims to make a significant impact in the fight against breast cancer.
Notification